Bergquist Erik R, Fischer Robert J, Sugden Kent D, Martin Brooke D
Department of Chemistry, University of Montana, 32 Campus Drive, Missoula, MT 59812, USA.
J Organomet Chem. 2009 Mar 15;694(6):973-980. doi: 10.1016/j.jorganchem.2008.12.028.
Inorganic arsenic that is ingested through drinking water or inhalation is metabolized by biological methylation pathways into organoarsenical metabolites. It is now becoming understood that this metabolism that was formerly considered to be detoxification may contribute as much or more to increasing the toxicity of arsenic. One proposed mode of the toxic action of arsenic and its organoarsenic metabolites is through its binding to proteins and inactivating their enzymatic activity. The classic case has been considered the affinity of the proximal 1,3 sulfhydryl groups of the lipoic acid cofactor of the pyruvate dehydrogenase complex for arsenic. A 2:1 stoichiometry of sulfhydryl to arsenic groups has been measured in proteins and arsenical complexes can be synthesized using free D,L-lipoic acid. The relative importance of this site for arsenic binding has come in to question through the use of methylating bifunctional arsenic complexes that suggested the methylation of an active site histidine may also be important, and the suggestion that arsenic inhibits the pyruvate dehydrogenase complex indirectly by elevating mitochondrial hydrogen peroxide generation. In order to separate the effects of direct trivalent arsenite toxicity from that of hydrogen peroxide and activated oxygen, we studied the inhibition of the PDH complex under conditions that did not generate hydrogen peroxide but did expose the lipoic acid group in its reduced state to arsenicals. We also studied the effects of arsenicals in the inhibition of the α-ketoglutarate dehydrogenase complex. We found that only trivalent arsenical compounds inhibited the activity of both dehydrogenase complexes and only when the lipoic acid was in its reduced form. Arsenite inhibited both enzyme complexes approximately equivalently while monomethylarsenite inhibited the PDH complex to a greater extent than the KGDH complex - although both complexes were very sensitive to inhibition by this complex. Dimethylarsenite inhibition of both complexes was only observed with longer pre-incubation periods. Cumulative inhibition by the reduced arsenical was observed for all complexes indicating a binding mode of inhibition that is dependent upon lipoic acid being in its reduced state.
通过饮水或吸入摄入的无机砷通过生物甲基化途径代谢为有机砷代谢物。现在人们逐渐认识到,这种以前被认为是解毒的代谢过程可能对增加砷的毒性起到同样甚至更大的作用。一种关于砷及其有机砷代谢物毒性作用的推测模式是,它们与蛋白质结合并使其酶活性失活。经典的例子是丙酮酸脱氢酶复合体的硫辛酸辅因子近端的1,3巯基对砷的亲和力。在蛋白质中已测得巯基与砷基团的化学计量比为2:1,并且可以使用游离的D,L-硫辛酸合成砷化合物。通过使用甲基化双功能砷配合物,对该位点在砷结合中的相对重要性提出了质疑,这表明活性位点组氨酸的甲基化可能也很重要,并且有人提出砷通过增加线粒体过氧化氢的产生间接抑制丙酮酸脱氢酶复合体。为了将直接的三价亚砷酸盐毒性与过氧化氢和活性氧的影响区分开来,我们研究了在不产生过氧化氢但使还原态的硫辛酸基团暴露于砷化合物的条件下丙酮酸脱氢酶复合体的抑制情况。我们还研究了砷化合物对α-酮戊二酸脱氢酶复合体的抑制作用。我们发现只有三价砷化合物能抑制这两种脱氢酶复合体的活性,并且只有当硫辛酸处于还原形式时才会发生抑制。亚砷酸盐对这两种酶复合体的抑制作用大致相当,而一甲基亚砷酸盐对丙酮酸脱氢酶复合体的抑制作用比对α-酮戊二酸脱氢酶复合体的抑制作用更大——尽管这两种复合体对该化合物的抑制都非常敏感。只有在较长的预孵育期后才观察到二甲基亚砷酸盐对这两种复合体的抑制作用。所有复合体都观察到了还原态砷的累积抑制作用,这表明抑制的结合模式取决于硫辛酸处于还原态。